CombiGene AB (publ) presents interim report for third quarter 2017 at an earlier date than planned

October 26, 2017

Since work on the Q3 interim report has progressed more quickly than expected, the Board of Directors of CombiGene has decided to publish the report on 1 November, 2017.

Share

News

September 15, 2023

CombiGene chooses CDMO partner for the COZY01 pain project

September 8, 2023

New issue of Ingeneious, no 4 2023

September 5, 2023

Epilepsy Project CGO1 progressing through optimization activities in preparation for in-human studies

August 25, 2023

Interim report January – June 2023 for CombiGene AB (publ)

June 30, 2023

Jan Nilsson leaves his position as CEO of CombiGene – COO Peter Ekolind takes over as new CEO on September 1, 2023

June 29, 2023

CombiGene forms prominent Scientific Advisory Board within the pain program COZY

June 28, 2023

New issue of Ingeneious, no 3 2023

May 25, 2023

Bulletin from the annual general meeting of CombiGene AB (publ)